Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer

Go back to Candel Therapeutics Appoints Mark Sims as Chief Commercial Officer
(NASDAQ: CADL) Delayed: 9.56 -0.3 (3.04%)
Previous Close $9.86    52 Week High
Open $9.86    52 Week Low
Day High $9.97    P/E N/A 
Day Low $9.46    EPS
Volume 1,012,020